Corporate ProfileNantHealth is a next-generation, evidence-based, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses. NantHealth‘s unique systems-based approach to personalized healthcare integrates novel diagnostics with large-scale, biometric and phenotypic data to track patient outcomes and deliver precision medicine. In addition, NantHealth’s adaptive learning system, CLINICS, continuously improves decision-making and further optimizes our clinical pathways and decision algorithms over time.
Stock Quote NH (Common Stock) $1.39 - 0.01 (0.71%)
Today's Open$1.41
Previous Close$1.40
Data as of 10/17/18 4:00 p.m. ET
Refresh quote

Data provided by Nasdaq. Minimum 15 minutes delayed.

Stock Chart
Stock chart for: NH.O.  Currently trading at $1.39 with a 52 week high of $4.44 and a 52 week low of $1.30.
Recent News

September 07, 2018

NantHealth Announces Appointment of Two Senior Executives to Lead Strategy, Business Development, and Global Sales

Nikko Khazana and Mark Mozley will help drive growth of NantHealth’s portfolio, including GPS Cancer® and Liquid GPS products CULVER CITY, Calif.--(BUSINESS WIRE)--Sep. 7, 2018-- NantHealth, Inc., (NASDAQ: NH), a leading next-generation, evidence-based, personalized healthcare company, announced new executive appointments to lead the company’s strategy and business development as well as global sales. Nikko Khazana will serve as...

Read More >

August 09, 2018

NantHealth Reports 2018 Second-Quarter Financial Results

Liquid GPS® Successfully Launched in Q2 Total Revenue in Q2 was $22.0 Million Revenue in 2017 Q2 included a large completed Connected Care device implementation of approximately $4 million, benefiting prior period revenue of $23.5 million SaaS revenue of $16.2 million in Q2, up 9% from $14.9 million in prior year Q2 In June...

Read More >

August 03, 2018

NantHealth to Report 2018 Second-Quarter Financial Results and Host Conference Call on Thursday, August 9

CULVER CITY, Calif.--(BUSINESS WIRE)--Aug. 3, 2018-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2018 second quarter on Thursday, August 9, 2018, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance. The conference call will ...

Read More >

Upcoming Events
There are currently no events scheduled.